Hims & Hers Health vs Natera
Hims & Hers Health reported revenue of $2.3 billion in fiscal 2025, about the same as Natera's $2.3 billion in fiscal 2025. Hims & Hers Health's revenue grew 59.0% in its latest year, and Natera's grew 35.9%. Hims & Hers Health had an operating margin of 4.5%, against -13.4% at Natera. Free cash flow was $57 million at Hims & Hers Health and $109 million at Natera.
Side by side
| Hims & Hers Health | Natera | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $2.3B | $2.3B |
| Revenue growth | 59.0% | 35.9% |
| Revenue growth a year, last 5 years | 73.6% | 42.6% |
| Gross margin | 73.8% | — |
| Operating margin | 4.5% | −13.4% |
| Net margin | 5.5% | −9.0% |
| Free cash flow | $57M | $109M |
| Free cash flow margin | 2.5% | 4.7% |
| Return on capital | 19.0% | — |
| Net debt to EBITDA | 2.5x | — |
| Dividends and buybacks | $90M | $0M |
| Change in diluted share count | 9.1% | 9.6% |
| Last close | $27.59 | $404.90 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $1.2 million, sold $19.3 million | sold $373.9 million |
| Piotroski F-score | 4 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Hims & Hers HealthNatera
Operating margin
Percent of revenue
Hims & Hers HealthNatera
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Hims & Hers HealthNatera
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Hims & Hers Health and Natera pages.